The Drug Enforcement Administration’s (DEA) administrative hearing on cannabis rescheduling saw both sides make their closing arguments on Wednesday, July
Ascend Wellness Holdings (CSE: AAWH-U.CN / OTCQX: AAWH) has become the latest US multi-state cannabis operator to target an uplisting
Tomorrow (July 15, 2026) the landmark administrative hearing on US cannabis rescheduling will come to a close. Today (July 14),
On Monday (June 29), the most consequential hearing in the history of US cannabis policy began proceedings, as the DEA
On June 29, 2026, one of the most consequential hearings in the history of US cannabis policy, the crucial DEA
In the weeks since cannabis under a state medical licence was moved to Schedule III, US multi-state operators (MSOs) have
Trulieve’s uplisting to the NYSE, the first of its kind in US history, has undoubtedly caught the attention of every
The critical June 29 administrative hearing, set to determine whether the US will extend rescheduling efforts to recreational cannabis, is
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug
Since President Trump issued an executive order to expedite cannabis rescheduling in December 2025, questions over the legal implications of this
As the federal campaign to clamp down on intoxicating hemp in the US rolls on, the Drug Enforcement Administration (DEA)
As the industry’s (more than justified) excitement over last week’s rescheduling announcement begins to subside, the regulatory reality is settling
The White House’s commitment to push through rescheduling has been challenged by a Democratic Senator, who has demanded answers on
US cannabis rescheduling, much like President Donald Trump who is rightly credited for finally pushing it forward, has sucked all
As the excitement around President Donald Trump’s executive order to push forward with cannabis rescheduling has faded, the bill is
Terrance Cole, has been confirmed as the new permanent head of the Drug Enforcement Administration (DEA), and will now be responsible for the future of the landmark cannabis rescheduling project.
The US cannabis rescheduling project, which has been stuck in limbo since being ‘temporarily’ shelved six months ago, is now facing another existential threat from the government’s wide reaching budget.
The frozen US cannabis rescheduling process appears to be stuck in limbo for the foreseeable future, as the Drug Enforcement Administration’s (DEA’s) new management confirmed the process ‘remains pending’.
We won’t spam you
